Veterinary Diagnostics Company MI:RNA Raises $4 million Series A Funding
7.9.24
NovaQuest in the News
FibroGen Announces $50 Million Royalty Monetization Financing with NovaQuest Capital Management
11.7.22
Hansa Biopharma announces $70 million non-dilutive product finance transaction with NovaQuest Capital Management to support continued development of the company’s antibody-cleaving enzyme technology platform across multiple therapeutic areas while extending the expected cash runway through 2024
7.18.22
